Search Results

Bucladesine Attenuates Spatial Learning and Hippocampal Mitochondrial Impairments Induced by 3, 4-Methylenedioxymethamphetamine (MDMA).

• Authors : Taghizadeh G; Rehabilitation Research Center, Department of Occupational Therapy, School of Rehabilitation Sciences, Iran University of Medical Sciences, Tehran, Iran.; Mehdizadeh H

Subjects: Bucladesine/Bucladesine/Bucladesine/*administration & dosage ; Hippocampus/Hippocampus/Hippocampus/*drug effects ; Mitochondria/Mitochondria/Mitochondria/*drug effects

• Source: Neurotoxicity research [Neurotox Res] 2020 Jun; Vol. 38 (1), pp. 38-49. Date of Electronic Publication: 2020 Feb 27.Publisher: Springer Country of Publication: United States NLM ID: 100929017 Publication Model: Print-Electronic Cited Medium: Internet ISSN:

Record details

Effect of bucladesine, pentoxifylline, and H-89 as cyclic adenosine monophosphate analog, phosphodiesterase, and protein kinase A inhibitor on acute pain.

• Authors : Salehi F; Department of Pharmacology and Toxicology, Pharmaceutical Science Research Center, Tehran University of Medical Science, PO Box 14155-6451, Tehran, Iran.; Hosseini-Zare MS

Subjects: Acute Pain/Acute Pain/Acute Pain/*drug therapy ; Bucladesine/Bucladesine/Bucladesine/*therapeutic use ; Cyclic AMP/Cyclic AMP/Cyclic AMP/*analogs & derivatives

• Source: Fundamental & clinical pharmacology [Fundam Clin Pharmacol] 2017 Aug; Vol. 31 (4), pp. 411-419. Date of Electronic Publication: 2017 Apr 26.Publisher: Blackwell Science Country of Publication: England NLM ID: 8710411 Publication Model: Print-Electronic Cited Medium: Internet ISSN:

Record details

Reduction of autophagy markers mediated protective effects of JNK inhibitor and bucladesine on memory deficit induced by Aβ in rats.

• Authors : Mohammadi M; Department of Pharmacology and Toxicology, Pharmaceutical Sciences Research Centre, Faculty of Pharmacy, Tehran University of Medical Sciences, P.O. Box 14155-6451, Tehran, Iran.; Guan J

Subjects: Anthracenes/Anthracenes/Anthracenes/*therapeutic use ; Bucladesine/Bucladesine/Bucladesine/*therapeutic use ; JNK Mitogen-Activated Protein Kinases/JNK Mitogen-Activated Protein Kinases/JNK Mitogen-Activated Protein Kinases/*antagonists & inhibitors

• Source: Naunyn-Schmiedeberg's archives of pharmacology [Naunyn Schmiedebergs Arch Pharmacol] 2016 May; Vol. 389 (5), pp. 501-10. Date of Electronic Publication: 2016 Feb 22.Publisher: Springer Verlag Country of Publication: Germany NLM ID: 0326264 Publication Model: Print-Electronic Cited Medium: Internet ISSN:

Record details

Zinc Chloride and Lead Acetate-Induced Passive Avoidance Memory Retention Deficits Reversed by Nicotine and Bucladesine in Mice.

• Authors : Tabrizian K; Department of Pharmacology and Toxicology, Faculty of Pharmacy, Zabol University of Medical Sciences, Zabol, Iran.; Medicinal Plants Research Center, Zabol University of Medical Sciences, Zabol, Iran.

Subjects: Bucladesine/Bucladesine/Bucladesine/*therapeutic use ; Chlorides/Chlorides/Chlorides/*toxicity ; Memory Disorders/Memory Disorders/Memory Disorders/*chemically induced

• Source: Biological trace element research [Biol Trace Elem Res] 2016 Jan; Vol. 169 (1), pp. 106-13. Date of Electronic Publication: 2015 Jun 12.Publisher: Humana Press Country of Publication: United States NLM ID: 7911509 Publication Model: Print-Electronic Cited Medium: Internet ISSN:

Record details

The stable cyclic adenosine monophosphate analogue, dibutyryl cyclo-adenosine monophosphate (bucladesine), is active in a model of acute skin inflammation.

• Authors : Rundfeldt C; Steckel H; Sörensen T

Subjects: Anti-Inflammatory Agents/Anti-Inflammatory Agents/Anti-Inflammatory Agents/*therapeutic use ; Bucladesine/Bucladesine/Bucladesine/*therapeutic use ; Dermatitis/Dermatitis/Dermatitis/*drug therapy

• Source: Archives of dermatological research [Arch Dermatol Res] 2012 May; Vol. 304 (4), pp. 313-7.Publisher: Springer Verlag Country of Publication: Germany NLM ID: 8000462 Publication Model: Print Cited Medium: Internet ISSN: 1432-069X

Record details

Effects of pentoxifylline and H-89 on epileptogenic activity of bucladesine in pentylenetetrazol-treated mice.

• Authors : Hosseini-Zare MS; Department of Pharmacology and Toxicology, Pharmaceutical Sciences Research Center, Faculty of Pharmacy, Tehran University of Medical Sciences, Tehran, Iran.; Salehi F

Subjects: Bucladesine/Bucladesine/Bucladesine/*pharmacology ; Isoquinolines/Isoquinolines/Isoquinolines/*pharmacology ; Pentoxifylline/Pentoxifylline/Pentoxifylline/*pharmacology

• Source: European journal of pharmacology [Eur J Pharmacol] 2011 Nov 30; Vol. 670 (2-3), pp. 464-70. Date of Electronic Publication: 2011 Sep 21.Publisher: Elsevier Science Country of Publication: Netherlands NLM ID: 1254354 Publication Model: Print-Electronic Cited Medium: Internet ISSN:

Record details

Post-training intrahippocampal infusion of nicotine-bucladesine combination causes a synergistic enhancement effect on spatial memory retention in rats.

• Authors : Sharifzadeh M; Department of Pharmacology and Toxicology, Pharmaceutical Sciences and Medicinal Plants Research Centers, Tehran University of Medical Sciences, Tehran, Iran. ; Zamanian AR

Subjects: Bucladesine/Bucladesine/Bucladesine/*pharmacology ; Cyclic AMP-Dependent Protein Kinases/Cyclic AMP-Dependent Protein Kinases/Cyclic AMP-Dependent Protein Kinases/*antagonists & inhibitors ; Nicotine/Nicotine/Nicotine/*pharmacology

• Source: European journal of pharmacology [Eur J Pharmacol] 2007 May 21; Vol. 562 (3), pp. 212-20. Date of Electronic Publication: 2007 Feb 08.Publisher: Elsevier Science Country of Publication: Netherlands NLM ID: 1254354 Publication Model: Print-Electronic Cited Medium: Print ISSN:

Record details

Local interstitial chemotherapy with sustained release bucladesine in de novo glioblastoma multiforme: a preliminary study.

• Authors : Dalbasti T; Department of Neurosurgery, University of Ege, School of Medicine, Izmir, Turkey. ; Oktar N

Subjects: Bucladesine/Bucladesine/Bucladesine/*administration & dosage ; Bucladesine/Bucladesine/Bucladesine/*therapeutic use ; Glioblastoma/Glioblastoma/Glioblastoma/*drug therapy

• Source: Journal of neuro-oncology [J Neurooncol] 2002 Jan; Vol. 56 (2), pp. 167-74.Publisher: Springer Country of Publication: United States NLM ID: 8309335 Publication Model: Print Cited Medium: Print ISSN: 0167-594X (Print)

Record details

Agricola

Record details

Effect of vehicles on percutaneous absorption of bucladesine (dibutyryl cyclic AMP) in normal and damaged rat skin.

• Authors : Mafune E; Pharmaceutical Formulation Research Center, Daiichi Pharmaceutical Co., Ltd., Tokyo, Japan.; Takahashi M

Subjects: Bucladesine/Bucladesine/Bucladesine/*pharmacokinetics ; Skin/Skin/Skin/*injuries ; Skin Absorption/Skin Absorption/Skin Absorption/*drug effects

• Source: Biological & pharmaceutical bulletin [Biol Pharm Bull] 1995 Nov; Vol. 18 (11), pp. 1539-43.Publisher: Pharmaceutical Society of Japan Country of Publication: Japan NLM ID: 9311984 Publication Model: Print Cited Medium: Print ISSN:

Record details